Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Famous mineralogists visit UFS Geology

2017-04-25

From the left: Prof Marian Tredoux, Associate
Professor at the UFS Department of Geology;
Prof Giorgio Garuti; from the University of Leoben,
Dr Federica Zaccarini, also from the
University of Leoben and Dr Freddie Roelofse,
Head of the Department of Geology at the UFS.
Photo: Rulanzen Martin

Years of academic friendship and collaboration is what makes Prof Giorgio Garuti and Dr Federica Zaccarini return to the University of the Free State (UFS) every so often.

The world-renowned academic duo from the University of Leoben in Austria were guest lecturers at the UFS Department of Geology. “We are here because we have known Professor Marian Tredoux and the Geology Department, for a long time. We are really happy to be here, and to be given the opportunity to present talks,” said Dr Zaccarini. The two are experts in platinum-group element mineralogy and each has given their surname to minerals namely, the Garutiite and Zaccariniite minerals.

Visit great advantage for research
They are acclaimed experts on very small minerals (smaller than a hundredth of a millimetre) with emphasis on platinum group elements in chrome-rich rocks. “Their visit is a great advantage for us. We also conduct research on these minerals and can learn from them,” said Prof Marian Tredoux, affiliated researcher at the Department of Geology.

Dr Zaccarini gave a lecture on Chromitites, and associated platinum-group elements, in ophiolites on Wednesday 5 April 2017 and Dr Garuti presented a lecture on Uralian-Alaskan complexes: a puzzling source of platinum, on Thursday 6 April 2017. During the talks they examined the association of the platinum-group minerals with chromite, rather than sulphide, and how this association can lead to the formation of unusual platinum-group element ores.

Collaboration on various academic papers
They and Prof Tredoux have collaborated on various research articles over the past four years, which have been published in various important international scientific journals. “These journals play an important role in calculating the H-scale which measures how important a researcher’s work is on an international scale,” said Prof Tredoux.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept